Roivant Sciences Ltd. (ROIV) Misses Q2 EPS by 2c
Tweet
Share
E-mail
Get Alerts ROIV Hot Sheet
Join SI Premium – FREE
Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.25), $0.02 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $4.48 million versus the consensus estimate of $48.63 million.
For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Active options: TSLA NVDA SPCX MU AAPL AMD INTC AMZN
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
